当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析 - 现金流量表

普洛药业

(000739)

  

流通市值:184.49亿  总市值:184.56亿
流通股本:11.78亿   总股本:11.79亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,298,162,652.028,862,726,155.215,986,375,397.513,907,277,244.09
收到的税费返还119,072,429.83484,128,759.81366,708,211.74269,826,885.69
收到其他与经营活动有关的现金45,145,765.24328,214,960.87258,413,664.71165,927,548.45
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,462,380,847.099,675,069,875.896,611,497,273.964,343,031,678.23
购买商品、接受劳务支付的现金1,484,349,282.756,458,584,615.384,197,997,038.542,529,494,244.93
支付给职工以及为职工支付的现金310,068,540.29941,813,373.09619,943,029.57448,102,504.03
支付的各项税费191,187,769.34481,246,056.29393,637,579.9294,213,077.16
支付其他与经营活动有关的现金196,649,780.84762,062,757.05551,379,185.09328,848,611.43
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,182,255,373.228,643,706,801.815,762,956,833.13,600,658,437.55
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额280,125,473.871,031,363,074.08848,540,440.86742,373,240.68
二、投资活动产生的现金流量:
收回投资收到的现金-52,102,285.5645,273,824.718,014,434.64
处置固定资产、无形资产和其他长期资产收回的现金净额-8,961,893.47113,257.095,100
处置子公司及其他营业单位收到的现金净额7,600,00030,399,153.0130,400,00030,400,000
收到的其他与投资活动有关的现金-35,153,034.9825,835,345.4525,011,938.32
投资活动现金流入的平衡项目0000
投资活动现金流入小计7,600,000126,616,367.02101,622,427.2563,431,472.96
购建固定资产、无形资产和其他长期资产支付的现金195,490,715.85630,467,013.51417,045,927.79222,115,526.55
投资支付的现金-130,000,000123,199,95849,999,958
支付其他与投资活动有关的现金251,425.242,947,298.1822,178,252.7920,627,284.89
投资活动现金流出的平衡项目0000
投资活动现金流出小计195,742,141.05803,414,311.69562,424,138.58292,742,769.44
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-188,142,141.05-676,797,944.67-460,801,711.33-229,311,296.48
三、筹资活动产生的现金流量:
吸收投资收到的现金-375,000375,000-
其中:子公司吸收少数股东投资收到的现金-375,000375,000-
取得借款收到的现金260,000,0001,061,180,916.671,025,000,000695,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计260,000,0001,061,555,916.671,025,375,000695,000,000
偿还债务支付的现金210,000,000964,665,668.05950,200,000567,200,000
分配股利、利润或偿付利息支付的现金11,718,538.9383,021,977.07376,165,012.93364,497,623.7
支付其他与筹资活动有关的现金761,415.715,352,107.238,347,247.751,738,419.61
筹资活动现金流出平衡项目0000
筹资活动现金流出小计222,479,954.61,363,039,752.351,334,712,260.68933,436,043.31
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额37,520,045.4-301,483,835.68-309,337,260.68-238,436,043.31
四、汇率变动对现金及现金等价物的影响7,083,124.5127,492,395.9335,150,950.5237,622,206.77
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额136,586,502.7380,573,689.66113,552,419.37312,248,107.66
加:期初现金及现金等价物余额2,462,485,761.742,381,912,072.082,381,912,072.082,381,912,072.08
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,599,072,264.472,462,485,761.742,495,464,491.452,694,160,179.74
补充资料:
净利润-1,055,306,898.23-601,044,120.54
资产减值准备-106,487,344.7-46,392,871.62
固定资产和投资性房地产折旧-538,031,286.28-268,342,719.27
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-538,031,286.28-268,342,719.27
无形资产摊销-15,026,434.82-5,597,625.54
长期待摊费用摊销-5,926,894.02-2,948,564.03
处置固定资产、无形资产和其他长期资产的损失--1,328,848.13--6,480.27
固定资产报废损失-7,793,162.14-2,392,513.21
公允价值变动损失-19,228.93-13,486,536.21
财务费用-60,329,518.38--45,784,104.27
投资损失-18,064,111.37-787,930.38
递延所得税-3,643,266.88-15,473,029.89
其中:递延所得税资产减少-22,889,492.3-23,905,035.49
递延所得税负债增加--19,246,225.42--8,432,005.6
存货的减少--373,347,043.74--95,383,943.39
经营性应收项目的减少--571,625,127.25--352,539,541.12
经营性应付项目的增加-130,168,077.8-273,185,253.64
其他-36,867,869.65--
现金的期末余额-2,462,485,761.74-2,694,160,179.74
减:现金的期初余额-2,381,912,072.08-2,381,912,072.08
公告日期2024-04-182024-03-082023-10-192023-08-15
审计意见(境内)标准无保留意见
TOP↑